EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+3.34%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$547M
AUM Growth
-$7M
(-1.3%)
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Axogen
AXGN
|
+$20M |
| 2 |
Gyre Therapeutics
GYRE
|
+$5.66M |
Top Sells
| 1 |
ACUR
Acura Pharmaceuticals Inc
ACUR
|
+$42.3K |
Sector Composition
| 1 | Healthcare | 96.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $199M | 36.46% |
2,150,000
| – | – |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $137M | 24.98% |
4,592,047
| – | – |
|
|
CORI
3
DELISTED
Corium International, Inc.
CORI
| $87.5M | 15.99% |
9,353,304
| – | – |
|
|
ENTL
4
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $68.7M | 12.56% |
3,813,197
| – | – |
|
|
ELGX
5
DELISTED
Endologix Inc
ELGX
| $21.2M | 3.88% |
125,747
| – | – |
|
|
6
Axogen
AXGN
$753M
| $20M | 3.66% |
+4,861,111
| New | +$20M |
|
|
7
Gyre Therapeutics
GYRE
$718M
| $5.66M | 1.03% |
+10,483
| New | +$5.66M |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $4.6M | 0.84% |
1,956,397
-18,000
| -0.9% | -$42.3K |
|
9
MediciNova
MNOV
$60.8M
| $3.29M | 0.6% |
1,170,370
| – | – |
|